Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the key to restoring the lungs’ natural repair ability. The discovery could lead ...
Trevi Therapeutics, Inc. (NASDAQ:TRVI) revealed topline results on Monday from its Phase 2b CORAL trial of Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis (IPF) (N=165). The ...
Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...
Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non–Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine SOX1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback